nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Parosmia—Varenicline—nicotine dependence	0.0467	0.0467	CcSEcCtD
Gadoxetate—Intestinal obstruction—Varenicline—nicotine dependence	0.0445	0.0445	CcSEcCtD
Gadoxetate—Tenderness—Varenicline—nicotine dependence	0.0348	0.0348	CcSEcCtD
Gadoxetate—Blood pressure increased—Varenicline—nicotine dependence	0.0303	0.0303	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Varenicline—nicotine dependence	0.0294	0.0294	CcSEcCtD
Gadoxetate—Disorientation—Varenicline—nicotine dependence	0.0246	0.0246	CcSEcCtD
Gadoxetate—Renal failure acute—Varenicline—nicotine dependence	0.0238	0.0238	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Varenicline—nicotine dependence	0.0225	0.0225	CcSEcCtD
Gadoxetate—Irritability—Varenicline—nicotine dependence	0.021	0.021	CcSEcCtD
Gadoxetate—Hypokalaemia—Varenicline—nicotine dependence	0.02	0.02	CcSEcCtD
Gadoxetate—Abdominal distension—Varenicline—nicotine dependence	0.0192	0.0192	CcSEcCtD
Gadoxetate—Dysphagia—Varenicline—nicotine dependence	0.019	0.019	CcSEcCtD
Gadoxetate—Bronchitis—Varenicline—nicotine dependence	0.0183	0.0183	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Varenicline—nicotine dependence	0.0167	0.0167	CcSEcCtD
Gadoxetate—Myocardial infarction—Varenicline—nicotine dependence	0.0166	0.0166	CcSEcCtD
Gadoxetate—Conjunctivitis—Varenicline—nicotine dependence	0.0165	0.0165	CcSEcCtD
Gadoxetate—Hypoaesthesia—Varenicline—nicotine dependence	0.0151	0.0151	CcSEcCtD
Gadoxetate—Connective tissue disorder—Varenicline—nicotine dependence	0.015	0.015	CcSEcCtD
Gadoxetate—Cardiac disorder—Varenicline—nicotine dependence	0.0141	0.0141	CcSEcCtD
Gadoxetate—Angiopathy—Varenicline—nicotine dependence	0.0138	0.0138	CcSEcCtD
Gadoxetate—Immune system disorder—Varenicline—nicotine dependence	0.0138	0.0138	CcSEcCtD
Gadoxetate—Mediastinal disorder—Varenicline—nicotine dependence	0.0137	0.0137	CcSEcCtD
Gadoxetate—Chills—Varenicline—nicotine dependence	0.0137	0.0137	CcSEcCtD
Gadoxetate—Arrhythmia—Varenicline—nicotine dependence	0.0136	0.0136	CcSEcCtD
Gadoxetate—Flatulence—Varenicline—nicotine dependence	0.0131	0.0131	CcSEcCtD
Gadoxetate—Dysgeusia—Varenicline—nicotine dependence	0.013	0.013	CcSEcCtD
Gadoxetate—Back pain—Varenicline—nicotine dependence	0.0128	0.0128	CcSEcCtD
Gadoxetate—Vision blurred—Varenicline—nicotine dependence	0.0125	0.0125	CcSEcCtD
Gadoxetate—Tremor—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Gadoxetate—Ill-defined disorder—Varenicline—nicotine dependence	0.0123	0.0123	CcSEcCtD
Gadoxetate—Agitation—Varenicline—nicotine dependence	0.0122	0.0122	CcSEcCtD
Gadoxetate—Malaise—Varenicline—nicotine dependence	0.012	0.012	CcSEcCtD
Gadoxetate—Vertigo—Varenicline—nicotine dependence	0.0119	0.0119	CcSEcCtD
Gadoxetate—Syncope—Varenicline—nicotine dependence	0.0119	0.0119	CcSEcCtD
Gadoxetate—Palpitations—Varenicline—nicotine dependence	0.0117	0.0117	CcSEcCtD
Gadoxetate—Loss of consciousness—Varenicline—nicotine dependence	0.0116	0.0116	CcSEcCtD
Gadoxetate—Cough—Varenicline—nicotine dependence	0.0116	0.0116	CcSEcCtD
Gadoxetate—Convulsion—Varenicline—nicotine dependence	0.0115	0.0115	CcSEcCtD
Gadoxetate—Chest pain—Varenicline—nicotine dependence	0.0113	0.0113	CcSEcCtD
Gadoxetate—Anxiety—Varenicline—nicotine dependence	0.0112	0.0112	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0112	0.0112	CcSEcCtD
Gadoxetate—Discomfort—Varenicline—nicotine dependence	0.0111	0.0111	CcSEcCtD
Gadoxetate—Dry mouth—Varenicline—nicotine dependence	0.011	0.011	CcSEcCtD
Gadoxetate—Oedema—Varenicline—nicotine dependence	0.0108	0.0108	CcSEcCtD
Gadoxetate—Infection—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Gadoxetate—Shock—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Gadoxetate—Nervous system disorder—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Gadoxetate—Tachycardia—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Gadoxetate—Skin disorder—Varenicline—nicotine dependence	0.0105	0.0105	CcSEcCtD
Gadoxetate—Hyperhidrosis—Varenicline—nicotine dependence	0.0105	0.0105	CcSEcCtD
Gadoxetate—Anorexia—Varenicline—nicotine dependence	0.0103	0.0103	CcSEcCtD
Gadoxetate—Hypotension—Varenicline—nicotine dependence	0.0101	0.0101	CcSEcCtD
Gadoxetate—Dyspnoea—Varenicline—nicotine dependence	0.00964	0.00964	CcSEcCtD
Gadoxetate—Decreased appetite—Varenicline—nicotine dependence	0.0094	0.0094	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00934	0.00934	CcSEcCtD
Gadoxetate—Fatigue—Varenicline—nicotine dependence	0.00933	0.00933	CcSEcCtD
Gadoxetate—Constipation—Varenicline—nicotine dependence	0.00925	0.00925	CcSEcCtD
Gadoxetate—Feeling abnormal—Varenicline—nicotine dependence	0.00891	0.00891	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00885	0.00885	CcSEcCtD
Gadoxetate—Urticaria—Varenicline—nicotine dependence	0.00859	0.00859	CcSEcCtD
Gadoxetate—Abdominal pain—Varenicline—nicotine dependence	0.00855	0.00855	CcSEcCtD
Gadoxetate—Body temperature increased—Varenicline—nicotine dependence	0.00855	0.00855	CcSEcCtD
Gadoxetate—Hypersensitivity—Varenicline—nicotine dependence	0.00797	0.00797	CcSEcCtD
Gadoxetate—Asthenia—Varenicline—nicotine dependence	0.00776	0.00776	CcSEcCtD
Gadoxetate—Pruritus—Varenicline—nicotine dependence	0.00765	0.00765	CcSEcCtD
Gadoxetate—Diarrhoea—Varenicline—nicotine dependence	0.0074	0.0074	CcSEcCtD
Gadoxetate—Dizziness—Varenicline—nicotine dependence	0.00715	0.00715	CcSEcCtD
Gadoxetate—Vomiting—Varenicline—nicotine dependence	0.00688	0.00688	CcSEcCtD
Gadoxetate—Rash—Varenicline—nicotine dependence	0.00682	0.00682	CcSEcCtD
Gadoxetate—Dermatitis—Varenicline—nicotine dependence	0.00681	0.00681	CcSEcCtD
Gadoxetate—Headache—Varenicline—nicotine dependence	0.00678	0.00678	CcSEcCtD
Gadoxetate—Nausea—Varenicline—nicotine dependence	0.00643	0.00643	CcSEcCtD
